303 related articles for article (PubMed ID: 31009853)
1. Protein corona variation in nanoparticles revisited: A dynamic grouping strategy.
Rezaei G; Daghighi SM; Haririan I; Yousefi I; Raoufi M; Rezaee F; Dinarvand R
Colloids Surf B Biointerfaces; 2019 Jul; 179():505-516. PubMed ID: 31009853
[TBL] [Abstract][Full Text] [Related]
2. How protein coronas determine the fate of engineered nanoparticles in biological environment.
Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
[TBL] [Abstract][Full Text] [Related]
3. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
[TBL] [Abstract][Full Text] [Related]
4. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
5. Combinatory interpretation of protein corona and shear stress for active cancer targeting of bioorthogonally clickable gelatin-oleic nanoparticles.
Meghani NM; Amin H; Park C; Cui JH; Cao QR; Choi KH; Lee BJ
Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110760. PubMed ID: 32279783
[TBL] [Abstract][Full Text] [Related]
6. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
[TBL] [Abstract][Full Text] [Related]
7. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review.
Kopac T
Int J Biol Macromol; 2021 Feb; 169():290-301. PubMed ID: 33340622
[TBL] [Abstract][Full Text] [Related]
8. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
Shang L; Nienhaus GU
Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
[TBL] [Abstract][Full Text] [Related]
9. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
Moraru C; Mincea M; Menghiu G; Ostafe V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
[TBL] [Abstract][Full Text] [Related]
10. A nano-bio interfacial protein corona on silica nanoparticle.
Zhang H; Peng J; Li X; Liu S; Hu Z; Xu G; Wu R
Colloids Surf B Biointerfaces; 2018 Jul; 167():220-228. PubMed ID: 29656205
[TBL] [Abstract][Full Text] [Related]
11. Synthetic and biological identities of polymeric nanoparticles influencing the cellular delivery: An immunological link.
Rezaei G; Daghighi SM; Raoufi M; Esfandyari-Manesh M; Rahimifard M; Mobarakeh VI; Kamalzare S; Ghahremani MH; Atyabi F; Abdollahi M; Rezaee F; Dinarvand R
J Colloid Interface Sci; 2019 Nov; 556():476-491. PubMed ID: 31473538
[TBL] [Abstract][Full Text] [Related]
12. Concentration-dependent protein adsorption at the nano-bio interfaces of polymeric nanoparticles and serum proteins.
Zhang TX; Zhu GY; Lu BY; Zhang CL; Peng Q
Nanomedicine (Lond); 2017 Nov; 12(22):2757-2769. PubMed ID: 29017387
[TBL] [Abstract][Full Text] [Related]
13. Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q.
Ding T; Sun J
Pharm Res; 2019 Dec; 37(1):10. PubMed ID: 31872347
[TBL] [Abstract][Full Text] [Related]
14. Nano-Bio Interface-Guided Nanoparticle Protein Corona Antigen for Immunoassays and Immunoimaging in a Complex Matrix.
Li L; Zhang Q; Chen B; Guo M; Yang Q; Zhang Y; Zhang M
ACS Appl Bio Mater; 2022 Feb; 5(2):841-852. PubMed ID: 35113530
[TBL] [Abstract][Full Text] [Related]
15. Liposome protein corona characterization as a new approach in nanomedicine.
Capriotti AL; Cavaliere C; Piovesana S
Anal Bioanal Chem; 2019 Jul; 411(19):4313-4326. PubMed ID: 30758528
[TBL] [Abstract][Full Text] [Related]
16. Nanotoxicology: advances and pitfalls in research methodology.
Azhdarzadeh M; Saei AA; Sharifi S; Hajipour MJ; Alkilany AM; Sharifzadeh M; Ramazani F; Laurent S; Mashaghi A; Mahmoudi M
Nanomedicine (Lond); 2015; 10(18):2931-52. PubMed ID: 26370561
[TBL] [Abstract][Full Text] [Related]
17. Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity.
Lee YK; Choi EJ; Webster TJ; Kim SH; Khang D
Int J Nanomedicine; 2015; 10():97-113. PubMed ID: 25565807
[TBL] [Abstract][Full Text] [Related]
18. Research progress and application opportunities of nanoparticle-protein corona complexes.
Huang W; Xiao G; Zhang Y; Min W
Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
[TBL] [Abstract][Full Text] [Related]
19. An Overview of Nanoparticle Protein Corona Literature.
Hajipour MJ; Safavi-Sohi R; Sharifi S; Mahmoud N; Ashkarran AA; Voke E; Serpooshan V; Ramezankhani M; Milani AS; Landry MP; Mahmoudi M
Small; 2023 Sep; 19(36):e2301838. PubMed ID: 37119440
[TBL] [Abstract][Full Text] [Related]
20. Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties.
Liu R; Jiang W; Walkey CD; Chan WC; Cohen Y
Nanoscale; 2015 Jun; 7(21):9664-75. PubMed ID: 25959034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
